Skip to main content
. Author manuscript; available in PMC: 2013 Jun 24.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2009 Dec 17;37(5):942–953. doi: 10.1007/s00259-009-1332-5

Fig. 1.

Fig. 1

TACs (mean %ID/g±SD) of VPM in whole brain beginning 120 min after administration of (a) 1.5, 2.6, 3.75, 7.5, 15 and 30 mg/kg of tariquidar (n=2 per dose) and (b) 0.3, 1, 2, 5, and 7.5 mg/kg of elacridar (n=2 per dose, except for 1 and 5 mg/kg (n=3)), respectively. In addition, horizontal PET summation images after administration of 1.5 (upper left), 2.6 (upper right), 3.75 (lower left) and 15 mg/kg (lower right) of tariquidar are shown (c)